These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30658176)

  • 1. Discrete Trajectories of Resolving and Persistent Pain in People With Rheumatoid Arthritis Despite Undergoing Treatment for Inflammation: Results From Three UK Cohorts.
    McWilliams DF; Dawson O; Young A; Kiely PDW; Ferguson E; Walsh DA
    J Pain; 2019 Jun; 20(6):716-727. PubMed ID: 30658176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting pain and early discontinuation of tumour necrosis factor-α-inhibitors in people with rheumatoid arthritis: results from the British society for rheumatology biologics register.
    McWilliams DF; Walsh DA
    BMC Musculoskelet Disord; 2016 Aug; 17():337. PubMed ID: 27515300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant inflammation and pain in early and established rheumatoid arthritis: Latent Class Analysis of Early Rheumatoid Arthritis Network and British Society for Rheumatology Biologics Register data.
    McWilliams DF; Ferguson E; Young A; Kiely PD; Walsh DA
    Arthritis Res Ther; 2016 Dec; 18(1):295. PubMed ID: 27964757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Longitudinal Course of Fatigue in Rheumatoid Arthritis: Results from the Norfolk Arthritis Register.
    Druce KL; Jones GT; Macfarlane GJ; Verstappen SM; Basu N
    J Rheumatol; 2015 Nov; 42(11):2059-65. PubMed ID: 26472420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD).
    Pisaniello HL; Lester S; Russell O; Black R; Tieu J; Richards B; Barrett C; Lassere M; March L; Buchbinder R; Whittle SL; Hill CL
    RMD Open; 2023 Jul; 9(3):. PubMed ID: 37507204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity.
    Pan Y; Norton S; Gwinnutt JM; Kearsley-Fleet L; Symmons DPM; Lunt M; Young A; ; Hyrich KL; Verstappen SMM
    PLoS One; 2019; 14(5):e0215999. PubMed ID: 31107887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of change in bodily pain in early rheumatoid arthritis: an inception cohort study.
    McWilliams DF; Zhang W; Mansell JS; Kiely PD; Young A; Walsh DA
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1505-13. PubMed ID: 22556121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the disparity between inflammation and disability in the 10-year outcomes of people with rheumatoid arthritis.
    Gwinnutt JM; Norton S; Hyrich KL; Lunt M; Combe B; Rincheval N; Ruyssen-Witrand A; Fautrel B; McWilliams DF; Walsh DA; Nikiphorou E; Kiely PDW; Young A; Chipping JR; MacGregor A; Verstappen SMM
    Rheumatology (Oxford); 2022 Nov; 61(12):4687-4701. PubMed ID: 35274696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatigue in early rheumatoid arthritis: data from the Early Rheumatoid Arthritis Network.
    Ifesemen OS; McWilliams DF; Norton S; Kiely PDW; Young A; Walsh DA
    Rheumatology (Oxford); 2022 Aug; 61(9):3737-3745. PubMed ID: 34958376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients receiving anti-TNF therapies experience clinically important improvements in RA-related fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Druce KL; Jones GT; Macfarlane GJ; Basu N
    Rheumatology (Oxford); 2015 Jun; 54(6):964-71. PubMed ID: 25313148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining Changes in Central and Peripheral Pain as Mediates of Fatigue Improvement: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Druce KL; Jones GT; Macfarlane GJ; Basu N
    Arthritis Care Res (Hoboken); 2016 Jul; 68(7):922-6. PubMed ID: 26605992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher education is associated with a better rheumatoid arthritis outcome concerning for pain and function but not disease activity: results from the EIRA cohort and Swedish rheumatology register.
    Jiang X; Sandberg ME; Saevarsdottir S; Klareskog L; Alfredsson L; Bengtsson C
    Arthritis Res Ther; 2015 Nov; 17():317. PubMed ID: 26546562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remaining Pain in Early Rheumatoid Arthritis Patients Treated With Methotrexate.
    Altawil R; Saevarsdottir S; Wedrén S; Alfredsson L; Klareskog L; Lampa J
    Arthritis Care Res (Hoboken); 2016 Aug; 68(8):1061-8. PubMed ID: 26784398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
    Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
    Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between depression and biologic treatment response in rheumatoid arthritis: An analysis of the British Society for Rheumatology Biologics Register.
    Matcham F; Davies R; Hotopf M; Hyrich KL; Norton S; Steer S; Galloway J
    Rheumatology (Oxford); 2018 May; 57(5):835-843. PubMed ID: 29447376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trajectories of functional limitation in early rheumatoid arthritis and their association with mortality.
    Norton S; Sacker A; Dixey J; Done J; Williams P; Young A;
    Rheumatology (Oxford); 2013 Nov; 52(11):2016-24. PubMed ID: 23934221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining Pathways to Improvements in Fatigue in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Druce KL; Jones GT; Macfarlane GJ; Basu N
    Arthritis Rheumatol; 2015 Sep; 67(9):2303-10. PubMed ID: 26108189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early undifferentiated connective tissue disease. IV.Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline.
    Alarcón GS; Willkens RF; Ward JR; Clegg DO; Morgan JG; Ma KN; Singer JZ; Steen VD; Paulus HE; Luggen ME; Polisson RP; Ziminski CM; Yarboro C; Williams HJ
    Arthritis Rheum; 1996 Mar; 39(3):403-14. PubMed ID: 8607889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A historical perspective concerning population-based and clinical studies of early arthritis and early rheumatoid arthritis.
    Sokka T; Pincus T
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S5-14. PubMed ID: 14969044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.